In the last trading session, 1.97 million Compass Pathways Plc ADR (NASDAQ:CMPS) shares changed hands as the company’s beta touched 2.22. With the company’s per share price at $4.35 changed hands at $0.37 or 9.30% during last session, the market valuation stood at $403.90M. CMPS’s last price was a discount, traded about -96.32% off its 52-week high of $8.54. The share price had its 52-week low at $2.49, which suggests the last value was 42.76% up since then.
Analysts gave the Compass Pathways Plc ADR (CMPS) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 3 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended CMPS as a Hold, 3 felt it is a Buy and 0 rated the stock as Underweight. Compass Pathways Plc ADR’s EPS for the current quarter is expected to be -0.36.
Compass Pathways Plc ADR (NASDAQ:CMPS) trade information
Instantly CMPS was in green as seen at the end of in last trading. With action 11.25%, the performance over the past five days has been green. The company’s shares are showing year-to-date upside of 15.08%, with the 5-day performance at 11.25% in the green. However, in the 30-day time frame, Compass Pathways Plc ADR (NASDAQ:CMPS) is 38.98% up.
The consensus price target for the stock as assigned by Wall Street analysts is 23, meaning bulls need an upside of 81.09% from its current market value. According to analyst projections, CMPS’s forecast low is 23 with 23 as the target high. To hit the forecast high, the stock’s price needs a -428.74% plunge from its current level, while the stock would need to soar -428.74% for it to hit the projected low.
Compass Pathways Plc ADR (CMPS) estimates and forecasts
According to analysts, the company will likely register a growth in its current quarter sales, forecast at 0.00%. The estimates for the next quarter sales put growth at 0.00%.
The 2025 estimates are for Compass Pathways Plc ADR earnings to increase by 29.56%, but the outlook for the next 5-year period is at 15.49% per year.
Compass Pathways Plc ADR (NASDAQ:CMPS)’s Major holders
CITADEL ADVISORS LLC holds the second largest percentage of outstanding shares, with 5.3652% or 3.67 million shares worth $22.16 million as of 2024-06-30.
Among Mutual Funds, the top two as of Apr 30, 2025 were ARK ETF Trust-ARK Genomic Revolution ETF and iShares Trust-iShares Biotechnology ETF. With 1.66 shares estimated at $7.22 million under it, the former controlled 1.79% of total outstanding shares. On the other hand, iShares Trust-iShares Biotechnology ETF held about 0.41% of the shares, roughly 381.09 shares worth around $1.66 million.
